Review





Similar Products

94
MedChemExpress apoptotic changes
Apoptotic Changes, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoptotic+changes/pm42089455-100-0-7?v=MedChemExpress
Average 94 stars, based on 1 article reviews
apoptotic changes - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Proimmune proimmune/pro-apoptotic versus anti-immune/anti-apoptotic genetic change summary
Proimmune/Pro Apoptotic Versus Anti Immune/Anti Apoptotic Genetic Change Summary, supplied by Proimmune, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoptotic+changes/pm31795829-128-3-1?v=Proimmune
Average 90 stars, based on 1 article reviews
proimmune/pro-apoptotic versus anti-immune/anti-apoptotic genetic change summary - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Selleck Chemicals apoptotic changes
Apoptotic Changes, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoptotic+changes/pm29595984-62-0-22?v=Selleck+Chemicals
Average 93 stars, based on 1 article reviews
apoptotic changes - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

99
Beyotime apoptotic morphology analysis apoptotic morphological changes
Apoptotic Morphology Analysis Apoptotic Morphological Changes, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoptotic+changes/pm27804109-78-0-14?v=Beyotime
Average 99 stars, based on 1 article reviews
apoptotic morphology analysis apoptotic morphological changes - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

97
Beyotime characteristic apoptotic morphological changes
Arenobufagin induces caspase-dependent apoptosis in non-small-cell lung cancer (NSCLC) cells. ( A ) A549 and NCI-H460 cells were treated with the indicated concentrations of arenobufagin for 24 h, and <t>apoptotic</t> morphological changes were evaluated by Hoechst 33258 staining; ( B , C ) A549 and NCI-H460 cells were treated with arenobufagin at the indicated concentrations for 24 h, and protein extracts were subjected to Western blot assay with indicated antibodies; ( D , E ) A549 cells were pre-treated with the caspase inhibitor Z-VAD (40 μΜ) for 1 h, followed by incubation with arenobufagin (Are, 25 nM) for 24 h; ( D ) poly (ADP-ribose) polymerase (PARP) cleavage was analyzed by Western blotting; ( E ) The cell viability was detected via trypan blue exclusion assay. ** p < 0.01, arenobufagin-treated group versus arenobufagin and Z-VAD combination group.
Characteristic Apoptotic Morphological Changes, supplied by Beyotime, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoptotic+changes/pmc06151516-119-0-15?v=Beyotime
Average 97 stars, based on 1 article reviews
characteristic apoptotic morphological changes - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

97
Beyotime apoptotic morphological changes
Arenobufagin induces caspase-dependent apoptosis in non-small-cell lung cancer (NSCLC) cells. ( A ) A549 and NCI-H460 cells were treated with the indicated concentrations of arenobufagin for 24 h, and <t>apoptotic</t> morphological changes were evaluated by Hoechst 33258 staining; ( B , C ) A549 and NCI-H460 cells were treated with arenobufagin at the indicated concentrations for 24 h, and protein extracts were subjected to Western blot assay with indicated antibodies; ( D , E ) A549 cells were pre-treated with the caspase inhibitor Z-VAD (40 μΜ) for 1 h, followed by incubation with arenobufagin (Are, 25 nM) for 24 h; ( D ) poly (ADP-ribose) polymerase (PARP) cleavage was analyzed by Western blotting; ( E ) The cell viability was detected via trypan blue exclusion assay. ** p < 0.01, arenobufagin-treated group versus arenobufagin and Z-VAD combination group.
Apoptotic Morphological Changes, supplied by Beyotime, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apoptotic+changes/pmc03886545-128-1-12?v=Beyotime
Average 97 stars, based on 1 article reviews
apoptotic morphological changes - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

Image Search Results


Arenobufagin induces caspase-dependent apoptosis in non-small-cell lung cancer (NSCLC) cells. ( A ) A549 and NCI-H460 cells were treated with the indicated concentrations of arenobufagin for 24 h, and apoptotic morphological changes were evaluated by Hoechst 33258 staining; ( B , C ) A549 and NCI-H460 cells were treated with arenobufagin at the indicated concentrations for 24 h, and protein extracts were subjected to Western blot assay with indicated antibodies; ( D , E ) A549 cells were pre-treated with the caspase inhibitor Z-VAD (40 μΜ) for 1 h, followed by incubation with arenobufagin (Are, 25 nM) for 24 h; ( D ) poly (ADP-ribose) polymerase (PARP) cleavage was analyzed by Western blotting; ( E ) The cell viability was detected via trypan blue exclusion assay. ** p < 0.01, arenobufagin-treated group versus arenobufagin and Z-VAD combination group.

Journal: Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry

Article Title: Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway

doi: 10.3390/molecules22091525

Figure Lengend Snippet: Arenobufagin induces caspase-dependent apoptosis in non-small-cell lung cancer (NSCLC) cells. ( A ) A549 and NCI-H460 cells were treated with the indicated concentrations of arenobufagin for 24 h, and apoptotic morphological changes were evaluated by Hoechst 33258 staining; ( B , C ) A549 and NCI-H460 cells were treated with arenobufagin at the indicated concentrations for 24 h, and protein extracts were subjected to Western blot assay with indicated antibodies; ( D , E ) A549 cells were pre-treated with the caspase inhibitor Z-VAD (40 μΜ) for 1 h, followed by incubation with arenobufagin (Are, 25 nM) for 24 h; ( D ) poly (ADP-ribose) polymerase (PARP) cleavage was analyzed by Western blotting; ( E ) The cell viability was detected via trypan blue exclusion assay. ** p < 0.01, arenobufagin-treated group versus arenobufagin and Z-VAD combination group.

Article Snippet: Characteristic apoptotic morphological changes were assessed by Hoechst 33258 staining, using the Hoechst staining kit (Beyotime, Haimen, China).

Techniques: Staining, Western Blot, Incubation, Trypan Blue Exclusion Assay